Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium.
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
There is a noticeable lack of targeted treatment options for marijuana dependence, in particular pharmacologic approaches. This is the first study evaluating a targeted pharmacologic approach for marijuana dependence. The goals of the study were to determine if such patients would seek pharmacologic treatment, whether these patients could be retained in treatment using a design previously developed for cocaine‐dependent patients, and especially whether divalproex sodium showed promise as a treatment agent for marijuana dependence. We found that marijuana‐dependent patients will seek treatment, and such patients can be adequately maintained in a pharmacologic trial. Regardless of treatment group, patients reported a significant reduction in their frequency and amount of marijuana use as well as a reduction in irritability. Given the lack of proven effective treatments for marijuana dependence, pharmacotherapies should be sought. The design of a preliminary clinical trial should include a psychosocial/behavioral intervention emphasizing motivation and medication compliance and a placebo control group.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,799
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Comprehensive Textbook of Psychiatry.
Hill, D. (1968) · PubMed Central · Cited by 762
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
Textbook of Substance Abuse Treatment
Seelye, E. E. (1995) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1995.49.2.300 · Cited by 384
Abstinence symptoms following smoked marijuana in humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050849 · Cited by 353
Budney, A. J., Higgins, S. T., Radonovich, K. J., & Novy, P. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.1051 · Cited by 318
Donovan, S. J., Stewart, J. W., Nunes, E. V., Quitkin, F. M., Parides, M., Daniel, W., Susser, E., & Klein, D. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.818 · Cited by 273
Self-citationCLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE*
Jones, R. T., Benowitz, N., & Bachman, J. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb49901.x · Cited by 270
Abstinence symptoms following oral THC administration to humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050848 · Cited by 261
Irritability: Definition, Assessment and Associated Factors
Snaith, R. P., & Taylor, C. M. (1985) · British Journal of Psychiatry · doi:10.1192/bjp.147.2.127 · Cited by 227
Principles of Addiction Medicine
Rukstalis, M. R., & Weinrieb, R. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-8-199910190-00034 · Cited by 218
Clinical Relevance of Cannabis Tolerance and Dependence
JONES, R. T., BENOWITZ, N. L., & HERNING, R. I. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02589.x · Cited by 191
Changes in aggressive behavior during withdrawal from long-term marijuana use
Kouri, E. M., Pope, H. G., & Lukas, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050951 · Cited by 161
The American Psychiatric Press Textbook of Psychopharmacology
Schatzberg, A. F., & Nemeroff, C. B. (1995) · Medical Entomology and Zoology · Cited by 150
Smith-Kielland, A., Skuterud, B., & Morland, J. (1999) · Journal of Analytical Toxicology · doi:10.1093/jat/23.5.323 · Cited by 130
Budney, A. J., Radonovich, K. J., Higgins, S. T., & Wong, C. J. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.4.419 · Cited by 112
PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
Kranzler, H. R. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.537 · Cited by 106
Sodium Valproate: Its Use in Primary Psychiatric Disorders
SUSAN, L. M., PAUL, E. K., & Harrison, G. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198702000-00004 · Cited by 95
The American Psychiatric Press Textbook of Psychopharmacology
Shen, W. W. (1998) · JAMA · doi:10.1001/jama.280.19.1715-a · Cited by 91
Cotariu, D., & Zaidman, J. L. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.5.890 · Cited by 88
Metabolism and Excretion of Mood Stabilizers and New Anticonvulsants
Ketter, T. A., Frye, M. A., Cora‐Locatelli, G., Kimbrell, T. A., & Post, R. M. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006990925122 · Cited by 75
Marijuana withdrawal syndrome in a woman
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1289 · Cited by 57
Divalproex Sodium in Substance Abusers With Mood Disorder
Albanese, M. J., Clodfelter, R. C., & Khantzian, E. J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1205 · Cited by 40
Fredericks, A., & Benowitz, N. L. (1980) · Psychopharmacology · doi:10.1007/bf00434412 · Cited by 37
Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
Bornheim, L. M., & Correia, M. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09333-2 · Cited by 21
Crude marihuana extract: EEG and behavioral effects of chronic oral administration in Rhesus monkeys
Stadnicki, S. W., Schaeppi, U. H., Rosenkrantz, H., & Braude, M. C. (1974) · Psychopharmacology · doi:10.1007/bf00421536 · Cited by 20
Marihuana withdrawal symptoms.
Bensusan, A. D. (1971) · BMJ · doi:10.1136/bmj.3.5766.112-b · Cited by 19
The Clinical Syndrome of Marijuana Dependence
Tennant, F. S. (1986) · Psychiatric Annals · doi:10.3928/0048-5713-19860401-09 · Cited by 19
Use of Quantitative Urinalysis in Monitoring Cocaine Use
Preston, K. L., Silverman, K., Schuster, C. R., & Cone, E. J. (1997) · PsycEXTRA Dataset · doi:10.1037/e495552006-014 · Cited by 18
Potentiating effect of cannabidiol on Δ9-tetrahydrocannabinol-induced changes in hepatic enzymes
Poddar, M. K., Bhattacharyya, K. C., & Ghosh, J. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90643-1 · Cited by 9
Research works printed but not linked: 12
- Johnston L, 1995, National Survey Results on Drug Use from the Monitoring the Future Study, 1975–1994
- DAWN, 2000, Year End 1998 Report Emergency Room Data from Drug Abuse Network Warning
- Frank B, 1995, Epidemiological trends in drug abuse, NIDA U.S. Department of Health and Human Services, NIH
- Kleber HD, 1999, Textbook of Substance Abuse Treatment, 251
- Levin FR, 2000, Pharmacological treatments for substance abuse, The Economics of Neuroscience, 2, 32
- Gold M, 1998, Principles of Addiction Medicine, 163
- Haney M, 1997, Abstinence Symptoms Following Oral THC Administration in Humans
- Nunes EV, 1997, Methodological recommendations for cocaine abuse clinical trials, NIDA Res Monogr, 175, 73
- Karler R, 1976, Proceedings of the Satellite Symposium of the 7th International Congress of Pharmacology, Paris
- First M, 1994, Structured Clinical Interview for DSM‐IV Axis I Personality Disorders SCID‐II, Version 2.0
- 10.1037/1064-1297.6.4.419 · doi:10.1037/1064-1297.6.4.419 · Paper page
- 2000, Physicians' Desk Reference
Cited by
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0056-7 · Cited by 358
“The use of valproic acid resulted in no benefit and even some worsening of symptoms in chronic cannabis users [95, 128].”
BackgroundThe cannabis withdrawal syndrome
Budney, A. J., & Hughes, J. R. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218592.00689.e5 · Cited by 349
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
“…exception, RCTs of cannabis dependent patients using divalproex, buproprion, lamotragine, gabapentin, and nefazadone found that none of these medications were effective for reducing cannabis or cocaine use among comorbid patients (Levin et al., 2004; Elkashef et al., 2008; Maremmani et al., 2010).”
Metadata
- Authors
- Levin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K.
- Affiliations
- New York State Psychiatric Institute (US)
- Corresponding author
- Levin, Frances Rudnick
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2004-01-02
- Volume
- 13
- Issue
- 1
- Pages
- 21-32
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W2023674219
- Cited by
- 113
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 8
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal on Addictions (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K02DA00465, DA-09236, K02DA000465, K02 DA00288, P50DA009236, K23 DA 00514, K02 DA 00451, K02DA000451, K02DA000288)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- cannabis use disorder, divalproex sodium, pharmacotherapy, treatment retention, irritability, substance use reduction, treatment-seeking behavior, medication adherence, psychosocial interventions
- MeSH terms
- Administration, Oral, Adult, Marijuana Abuse, Double-Blind Method, Female, Humans, Irritable Mood, Male, Patient Compliance, Placebos, Valproic Acid, Health Behavior, Treatment Outcome, Cross-Over Studies, GABA Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.